Stocks News

LAST PRICE
26.6170
TODAY'S CHANGE (%)
Trending Up4.3020 (19.2785%)

Bid / Lots
26.4900/ 2
Ask / Lots
26.7700/ 6
Open / Previous Close
25.9700 / 22.3150
Day Range
Low 24.2300
High 27.6100
52 Week Range
Low 12.4900
High 74.4900
Volume
1,104,164
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation, from 5 hours ago by Accesswire
  5 hours ago by Accesswire
  Companies Mentioned: NGNE
  NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neurogene Inc. ("Neurogene" or "the Company") (NASDAQ:NGNE). Investors who purchased Neurogene securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NGNE.
- Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: NGNE
  
  NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neurogene Inc. ("Neurogene" or "the Company") (NASDAQ:NGNE). Investors who purchased Neurogene securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NGNE.
- Neurogene Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - NGNE, from 8 hours ago by Accesswire
  8 hours ago by Accesswire
  Companies Mentioned: NGNE
  NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neurogene Inc. ("Neurogene Inc.") (NASDAQ:NGNE) concerning possible violations of federal securities laws.
- Neurogene Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - NGNE, from 8 hours ago by Dow Jones
  8 hours ago by Dow Jones
  Companies Mentioned: NGNE
  
  NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Neurogene Inc. ("Neurogene Inc.") (NASDAQ:NGNE) concerning possible violations of federal securities laws.
Yesterday
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE, from 19 hours ago by PR Newswire
  19 hours ago by PR Newswire
  Companies Mentioned: NGNE
  Pomerantz LLP is investigating claims on behalf of investors ofNeurogene Inc. ("Neurogene" or the "Company")(NASDAQ: NGNE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980.

Yesterday
- Compass Pathways to Participate in December Investor Conferences, from 23 hours ago by Dow Jones
  23 hours ago by Dow Jones
  Companies Mentioned: CMPS
- European Equities Traded in the US as American Depositary Receipts Rising Monday, from 11:13AM ET on Monday Nov 25, 2024 by MT Newswires
  11:13AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: BBVA, STM, EQNR, AMRN, CMPS, BRNS, OTLY, TCBP, SAN
- Top Premarket Gainers, from 7:41AM ET on Monday Nov 25, 2024 by MT Newswires
  7:41AM ET on Monday Nov 25, 2024 by MT Newswires
  Companies Mentioned: QTTB, RGTI, WLDS, PAHC, QMCO
Nov 21, 2024
- European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday, from 11:20AM ET on Thursday Nov 21, 2024 by MT Newswires
  11:20AM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: NOK, NVO, EQNR, GRFS, DAVA, BNTX, CMPS, SLN, SHEL
Nov 18, 2024
- DJ Aldeyra Therapeutics Shares Up, FDA to Review New Drug Application, from 3:05PM ET on Monday Nov 18, 2024 by Dow Jones
  3:05PM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: ALDX
- Aldeyra Therapeutics' Resubmitted Marketing Application for Eye Disease Drug Accepted by FDA, from 8:01AM ET on Monday Nov 18, 2024 by MT Newswires
  8:01AM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: ABBV, ALDX
- Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: ALDX
Nov 14, 2024
- Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference, from 7:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  7:00AM ET on Thursday Nov 14, 2024 by Dow Jones
  Companies Mentioned: ALDX
Nov 7, 2024
- Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 6:59AM ET on Thursday Nov 07, 2024 by PR Newswire
  6:59AM ET on Thursday Nov 07, 2024 by PR Newswire
  Companies Mentioned: QTTB
- Press Release: Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 6:59AM ET on Thursday Nov 07, 2024 by Dow Jones
  6:59AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: QTTB

Neurogene Inc
NASDAQ:NGNEUnited States

Search Criteria

Today

Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation, from 5 hours ago by Accesswire

Neurogene Inc. (NGNE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation, from 5 hours ago by Dow Jones

Neurogene Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - NGNE, from 8 hours ago by Accesswire

Neurogene Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - NGNE, from 8 hours ago by Dow Jones

Yesterday

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neurogene Inc. - NGNE, from 19 hours ago by PR Newswire

Peers Headlines

Yesterday

Compass Pathways to Participate in December Investor Conferences, from 23 hours ago by Dow Jones

European Equities Traded in the US as American Depositary Receipts Rising Monday, from 11:13AM ET on Monday Nov 25, 2024 by MT Newswires

Top Premarket Gainers, from 7:41AM ET on Monday Nov 25, 2024 by MT Newswires

Nov 21, 2024

European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday, from 11:20AM ET on Thursday Nov 21, 2024 by MT Newswires

Nov 18, 2024

DJ Aldeyra Therapeutics Shares Up, FDA to Review New Drug Application, from 3:05PM ET on Monday Nov 18, 2024 by Dow Jones

Aldeyra Therapeutics' Resubmitted Marketing Application for Eye Disease Drug Accepted by FDA, from 8:01AM ET on Monday Nov 18, 2024 by MT Newswires

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones

Nov 14, 2024

Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference, from 7:00AM ET on Thursday Nov 14, 2024 by Dow Jones

Nov 7, 2024

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 6:59AM ET on Thursday Nov 07, 2024 by PR Newswire

Press Release: Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 6:59AM ET on Thursday Nov 07, 2024 by Dow Jones